Orphan Drugs Worth $64 Billion by 2028 and This Micro Cap Could Have One by That Time
November 07 2023 - 3:01PM
AllPennyStocks.com
There are very good reasons that stocks
generally gain in value after a company receives orphan drug
designation (ODD). A
To read the full story on AllPennyStocks.com, click
here.
Nurexone Biologic (TSXV:NRX)
Historical Stock Chart
From Jan 2025 to Feb 2025
Nurexone Biologic (TSXV:NRX)
Historical Stock Chart
From Feb 2024 to Feb 2025
